HomeInsights52 Week High Stocks

Jagsonpal Pharmaceuticals Ltd 52 Week High

Jagsonpal Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 1.1 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

17.5 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

YEARHIGH

₹ 627

Last updated on: Nov 07, 2024

Key Highlights

  • The 52 Week HIGH of Jagsonpal Pharmaceuticals Ltd is ₹ 627 as of 07 Nov 24.

Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

No data available

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024598.75
06 Nov 2024609.5
05 Nov 2024599.45
04 Nov 2024537.55
01 Nov 2024548.9
31 Oct 2024543.3
30 Oct 2024521.95
29 Oct 2024467.65
28 Oct 2024469.5
25 Oct 2024449.45

Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals to table results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 202412:13

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the comp...

Read more

13 Aug 202414:22

News

Jagsonpal Pharmaceuticals declare Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

01 Aug 202411:06

News

Jagsonpal Pharmaceuticals completes acquisition of India and Bhutan biz of Yash Pharma

Jagsonpal Pharmaceuticals completed the acquisition of India & Bhutan business of Yash Pha...

Read more

31 May 202414:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

21 May 202409:56

News

Jagsonpal Pharmaceuticals Ltd leads losers in 'B' group

Pakka Ltd, IFGL Refractories Ltd, Mangalore Chemicals & Fertilizers Ltd and SBC Exports Lt...

Read more

05 Feb 202414:45

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Jagsonpal Pharmaceuticals Ltd

What is the significance of Jagsonpal Pharmaceuticals Ltd reaching its 52-week high?

Jagsonpal Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Jagsonpal Pharmaceuticals Ltd 52-week high?

Investors monitor Jagsonpal Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Jagsonpal Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Jagsonpal Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Jagsonpal Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Jagsonpal Pharmaceuticals Ltd at its 52-week high?

Before investing in Jagsonpal Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Jagsonpal Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Jagsonpal Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*